Real-time enrollment status for this systemic sclerosis cutaneous lupus e myopathies systemic lupus erythematosus clinical trial
Current Status
Recruiting
Checked: October 3, 2026 at 3:07 AM UTC
| NCT Number | NCT07691970 |
| Recruiting Status | Recruiting |
| Condition | Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus |
| Phase | PHASE3 |
| Target Enrollment | 1,072 participants |
| Active Locations | 15 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | October 2, 2026 (Yesterday) |
As of October 3, 2026: Clinical trial NCT07691970 is currently recruiting participants. This phase3 study for systemic sclerosis cutaneous lupus e myopathies systemic lupus erythematosus is actively seeking new participants at 15 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07691970 is actively recruiting participants as of October 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07691970 was last updated Yesterday (October 2, 2026). HelloStudys verifies this status automatically.